Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | MLYCD | O95822 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.39 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11253426 | 0.76 | LMNA (0.53) | CTSLLMNAPOLBKMT2AGAA | |
| SCHEMBL29502276 | 0.76 | HPGD (0.44) | LMNASMN1; SMN2 | |
| SCHEMBL190958 | 0.70 | GAA (0.50) | LMNAPOLBKMT2AGAATSHR | |
| SCHEMBL162587 | 0.70 | TP53 (0.44) | LMNAPOLBKMT2AHSD17B10GAA | |
| SCHEMBL18082339 | 0.70 | MAPT (0.60) | KMT2AALDH1A1MEN1SMN1; SMN2 | |
| Isoorotic Acid Methyl Ester SCHEMBL7487788 | 0.69 | GAA (0.53) | LMNAKMT2AGAAALDH1A1 | |
| SCHEMBL12050193 | 0.69 | GAA (0.45) | CTSLLMNAPOLBKMT2AGAA | |
| Dimethylamine SCHEMBL1524840 | 0.69 | KDM3B (0.56) | CTSLLMNAPOLBKMT2AHSD17B10 | |
| SCHEMBL10824795 | 0.69 | ALDH1A1 (0.43) | LMNAKMT2AHSD17B10GAAALDH1A1 | |
| SCHEMBL27606923 | 0.69 | LMNA (0.49) | CTSLLMNAPOLBKMT2AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114645051-A | Secretory immunoglobulin A (sIgA) binding nucleic acid molecule, sensor for sIgA analysis, and sIgA analysis method | 日本电气方案创新株式会社 | 2022-06-21 | — | — | CN | disclosed |
| CN-109715807-B | Secretory immunoglobulin A (sIgA) -binding nucleic acid molecule, sensor for sIgA analysis, and sIgA analysis method | 日本电气方案创新株式会社 | 2022-05-17 | — | — | CN | disclosed |
| CN-109715644-B | Nucleoside derivative or salt thereof, polynucleotide synthesis reagent, polynucleotide production method, polynucleotide, and bound nucleic acid molecule production method | 日本电气方案创新株式会社 | 2022-03-22 | — | — | CN | disclosed |
| CN-109715645-B | Nucleoside derivative or salt thereof, polynucleotide synthesis reagent, polynucleotide production method, polynucleotide, and bound nucleic acid molecule production method | 日本电气方案创新株式会社 | 2022-03-22 | — | — | CN | disclosed |
| US-11236342-B2 | Secretory immunoglobulin a (sIgA)-binding nucleic acid molecule, sIgA analysis sensor, and sIgA analysis method | NEC SOLUTION INNOVATORS, LTD. (JP) | 2022-02-01 | — | — | US | disclosed |
| EP-3783105-B1 | SECRETORY IMMUNOGLOBULIN A (SIGA)-BINDING NUCLEIC ACID MOLECULE, SENSOR FOR SIGA ANALYSIS, AND ANALYSIS METHOD FOR SIGA | NEC SOLUTION INNOVATORS LTD (JP) | 2021-11-03 | — | — | EP | disclosed |
| EP-3514237-B1 | SECRETORY IMMUNOGLOBULIN A (SIGA)-BINDING NUCLEIC ACID MOLECULE, SENSOR FOR SIGA ANALYSIS, AND ANALYSIS METHOD FOR SIGA | NEC SOLUTION INNOVATORS LTD (JP) | 2021-07-14 | — | — | EP | disclosed |
| EP-3514165-B1 | NUCLEOSIDE DERIVATIVE OR SALT THEREOF, REAGENT FOR SYNTHESIZING POLYNUCLEOTIDE, METHOD FOR PRODUCING POLYNUCLEOTIDE, POLYNUCLEOTIDE, AND METHOD FOR PRODUCING BINDING NUCLEIC ACID MOLECULE | NEC SOLUTION INNOVATORS LTD (JP) | 2021-05-19 | — | — | EP | disclosed |
| US-10934548-B2 | Wheat allergen-binding nucleic acid molecule and use thereof | NEC SOLUTION INNOVATORS, LTD. (JP) | 2021-03-02 | — | — | US | disclosed |
| EP-3783105-A1 | SECRETORY IMMUNOGLOBULIN A (SIGA)-BINDING NUCLEIC ACID MOLECULE, SENSOR FOR SIGA ANALYSIS, AND ANALYSIS METHOD FOR SIGA | NEC Solution Innovators, Ltd. (JP) | 2021-02-24 | — | — | EP | disclosed |
| US-20190211048-A1 | NUCLEOSIDE DERIVATIVE OR SALT THEREOF, POLYNUCLEOTIDE SYNTHESIS REAGENT, METHOD FOR PRODUCING POLYNUCLEOTIDE, POLYNUCLEOTIDE, AND METHOD FOR PRODUCING BINDING NUCLEIC ACID MOLECULE | NEC SOLUTION INNOVATORS, LTD. (JP) | 2019-07-11 | — | — | US | disclosed |
| EP-3078747-B1 | PEANUT-BINDING NUCLEIC ACID MOLECULE AND USE THEREOF | NEC SOLUTION INNOVATORS LTD (JP) | 2019-05-15 | — | — | EP | disclosed |
| US-20190071735-A1 | TARGET ANALYSIS METHOD AND TARGET ANALYSIS KIT FOR USE IN THE METHOD | NEC SOLUTION INNOVATORS, LTD. (JP) | 2019-03-07 | — | — | US | disclosed |
| EP-3406735-A1 | TARGET ANALYSIS METHOD AND TARGET ANALYSIS KIT FOR USE IN SAID METHOD | NEC Solution Innovators, Ltd. (JP) | 2018-11-28 | — | — | EP | disclosed |
| US-20180327746-A1 | Alpha-AMYLASE-BINDING NUCLEIC ACID MOLECULE AND USE THEREOF | NEC SOLUTION INNOVATORS, LTD. (JP) | 2018-11-15 | — | — | US | disclosed |
| EP-3378939-A1 | WHEAT ALLERGEN-BINDING NUCLEIC ACID MOLECULE AND USE THEREOF | NEC Solution Innovators, Ltd. (JP) | 2018-09-26 | — | — | EP | disclosed |
| US-9790508-B2 | Peanut-binding nucleic acid molecule and use thereof | NEC SOLUTION INNOVATORS, LTD. (JP) | 2017-10-17 | — | — | US | disclosed |
| US-20160298117-A1 | PEANUT-BINDING NUCLEIC ACID MOLECULE AND USE THEREOF | NEC SOLUTION INNOVATORS, LTD. (JP) | 2016-10-13 | — | — | US | disclosed |
| EP-3078747-A1 | PEANUT-BINDING NUCLEIC ACID MOLECULE AND USE THEREOF | NEC Solution Innovators, Ltd. (JP) | 2016-10-12 | — | — | EP | disclosed |
| CN-105814206-A | Peanut-binding nucleic acid molecules and uses thereof | 日本电气方案创新株式会社 | 2016-07-27 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10934548-B2 | Wheat allergen-binding nucleic acid molecule and use thereof | NOS1, NOS2, MICA | CTSL 3971/4885LMNA 2725/4885POLB 374/4885 |
| US-20190211048-A1 | NUCLEOSIDE DERIVATIVE OR SALT THEREOF, POLYNUCLEOTIDE SYNTHESIS REAGENT, METHOD FOR PRODUCING POLYNUCLEOTIDE, POLYNUCLEOTIDE, AND METHOD FOR PRODUCING BINDING NUCLEIC ACID MOLECULE | SNRPA1, SNRPB2, NSUN3 | CTSL 4786/4885LMNA 798/4885POLB 203/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.